Andrew M. Dahl
CIK: 0002022347
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edwards Lifesciences Corp
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 13, 2026EW
Edwards Lifesciences Corp
Tax Payment(F)Direct253 shares at avg. $84.37$21K - May 29, 2026EW
Edwards Lifesciences Corp
Sale(S)Direct568 shares at avg. $86.08$49K - May 8, 2026EW
Edwards Lifesciences Corp
Tax Payment(F)Direct289 shares at avg. $82.76$24K - May 7, 2026EW
Edwards Lifesciences Corp
Award(A)Direct3K shares- - May 7, 2026EW
Edwards Lifesciences Corp
Award(A)Direct4K shares- - Feb 22, 2026EW
Edwards Lifesciences Corp
Tax Payment(F)Direct176 shares at avg. $79.78$14K - Nov 13, 2025EW
Edwards Lifesciences Corp
Award(A)Direct1.2K shares- - Sep 13, 2025EW
Edwards Lifesciences Corp
Tax Payment(F)Direct262 shares at avg. $77.57$20K - May 8, 2025EW
Edwards Lifesciences Corp
Award(A)Direct3.3K shares- - Feb 22, 2025EW
Edwards Lifesciences Corp
Tax Payment(F)Direct176 shares at avg. $73.30$13K - Sep 13, 2024EW
Edwards Lifesciences Corp
Award(A)Direct2.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 13, 2026 | EW Edwards Lifesciences Corp | Tax Payment(F) | 253 | $84.37 | $21,346 | Direct |
| May 29, 2026 | EW Edwards Lifesciences Corp | Sale(S) | 568 | $86.08 | $48,853 | Direct |
| May 8, 2026 | EW Edwards Lifesciences Corp | Tax Payment(F) | 289 | $82.76 | $23,918 | Direct |
| May 7, 2026 | EW Edwards Lifesciences Corp | Award(A) | 3,020 | - | $0 | Direct |
| May 7, 2026 | EW Edwards Lifesciences Corp | Award(A) | 3,985 | - | $0 | Direct |
| Feb 22, 2026 | EW Edwards Lifesciences Corp | Tax Payment(F) | 176 | $79.78 | $14,041 | Direct |
| Nov 13, 2025 | EW Edwards Lifesciences Corp | Award(A) | 1,160 | - | - | Direct |
| Sep 13, 2025 | EW Edwards Lifesciences Corp | Tax Payment(F) | 262 | $77.57 | $20,323 | Direct |
| May 8, 2025 | EW Edwards Lifesciences Corp | Award(A) | 3,335 | - | - | Direct |
| Feb 22, 2025 | EW Edwards Lifesciences Corp | Tax Payment(F) | 176 | $73.30 | $12,901 | Direct |
| Sep 13, 2024 | EW Edwards Lifesciences Corp | Award(A) | 2,920 | - | $0 | Direct |
1-11 of 11 transactions
About Dahl Andrew M.
Dahl Andrew M. (SEC CIK 0002022347) files insider reports with the SEC as SVP, Corporate Controller of Edwards Lifesciences Corp (EW).
Signal8 holds 9 ownership filings by Dahl Andrew M., all Form 4s, filed between Sep 16, 2024 and Sep 14, 2026. Those filings report 11 transactions, from Sep 13, 2024 to Sep 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dahl Andrew M.'s filings is in IRVINE, CA.
Recent filings by Dahl Andrew M.
- Sep 13, 2026: Tax withholding of EW shares (Form 4, code F).
- May 29, 2026: Open-market sale of EW shares (Form 4, code S).
- May 8, 2026: Tax withholding of EW shares (Form 4, code F).
- May 7, 2026: Grants or awards of EW shares (2 lines, Form 4, code A).
- Feb 22, 2026: Tax withholding of EW shares (Form 4, code F).
Other insiders filing for Edwards Lifesciences Corp (EW)
- Lippis Daniel J., CVP, TAVR
- Markowitz Wayne, CVP, JAPAC
- Chopra Daveen, CVP, TMTT, Surgical & IHFM
- Bruls Annette, CVP, EMEACLA
- Zovighian Bernard J, CEO
- Mistras Theodora, CVP, Chief Financial Officer